Breast cancer is second only to lung cancer as the leading cancer cause of death in women. In 2010 207,000 women will be diagnosed with breast cancer and over 39,000 are expected to die from breast cancer.
Nevertheless, ongoing research and recent advances in both diagnostic and therapeutic modalities continue to make breast cancer management a rapidly evolving area in which the practitioner will want to be fully updated on current developments.
Breast Cancer offers a comprehensive and in-depth review of the current literature of breast cancer. Chapters examine risk factors and prevention strategies, trends and developments in imaging, surgical management, radiotherapy advances, adjuvant endocrine and chemotherapies, targeted metastatic therapy, and the role of bisphosphonates and novel bone agents in breast cancer. With this volume the oncology practitioner will have a full and current overview of all significant current trends in this important area of oncology.
About the Series:
Emerging Cancer Therapeutics is an invited review publication providing a through analysis of key clinical research related to cancer therapeutics, including a discussion and assessment of current evidence, current clinical best practice, and likely near future developments. There is an emphasis throughout on multidisciplinary approaches to the specialty, as well as on quality and outcomes analysis. Published three times a year Emerging Cancer Therapeutics provides authoritative, thorough assessments of advances in therapeutics in all major areas of oncology, both solid and hematologic malignancies, with a focus on advances in medical and biological therapies with emerging clinical impact and encompassing new technologies with implications for management such as molecular imaging.
Features of Emerging Cancer Therapeutics include:
•Editorial board of nationally recognized experts across the spectrum
of Cancer Therapeutics
•In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
•Issues edited by an authority in specific subject area
•Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
•Emphasizes multidisciplinary approaches to research and practice
1. Risk Factors and Strategies for Prevention of Breast Cancer, Sameh Mikhail and Jennifer Eng-Wong, 2. Current Trends and New Developments in Breast Cancer Imaging, Lilian C. Wang, Paula Grabler, Mariana Solari, Sandra S. Rao, and Patricia J. Karstaedt, 3. Update on the Surgical Management of Breast Cancer: Areas of Controversy and Advancement, Fatema Al-Mushawah and Rebecca Aft, 4. Advances in Radiotherapy for Breast Cancer, Sharad Goyal, Atif J. Khan, and Bruce G. Haffty, 5. Adjuvant Chemotherapy for Breast Cancer: Updates and New Perspectives, Conleth G. Murphy, Clifford A. Hudis, and Heather L. McArthur , 6. Endocrine Therapy for Early Breast Cancer , Mary Cianfrocca , 7. HER2-Targeted Treatment in the Adjuvant Setting for Breast Cancer , Serena T. Wong and Antoinette R. Tan, 8. Endocrine Treatment for Metastatic Breast Cancer, Shamsuddin Virani and Jame Abraham , 9. Chemotherapy for Metastatic Breast Cancer , Hamid R. Mirshahidi and Jame Abraham , 10. Targeted Therapy for Metastatic Breast Cancer, Amelia B. Zelnak and Ruth O'Regan, 11. Management of HER2-Positive Metastatic Breast Cancer: Standard and New Approaches , Nabila Chowdhury and Sandra M. Swain, 12. Treatment Options for Triple-Negative Breast Cancer, Katherine Enright and Rebecca Dent, 13. The Expanding Role of Bisphosphonates and Novel Bone Agents in Breast Cancer , Larissa A. Korde and Julie R. Gralow, 14. Principles of Breast Cancer Genomics,Olivier D. Loudig and Joseph A. Sparano
About the editors
Antoinette Tan, MD, MHSc, Associate Professor of Medicine, Division of Medical Oncology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, The Cancer Institute of New Jersey, New Brunswick, New Jersey
Jame Abraham, MD, FACP, Bonnie Wells Wilson Distingushed Professor and Eminent Scholar, Chief, Section of Hematology-Oncology, and Medical Director, Mary Babb Randolph Cancer Center, West Virginia University.